BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Engin G, Eraslan S, Kayserili H, Kapran Y, Akman H, Akyuz A, Aykan NF. Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: A family report. World J Radiol 2017; 9(9): 365-370 [PMID: 29098070 DOI: 10.4329/wjr.v9.i9.365]
URL: https://www.wjgnet.com/1007-9327/full/v9/i9/365.htm
Number Citing Articles
1
Jing Qi, He-Li Liu, Feng Ren, Sheng Liu, Wei Shi, Wei-Hang Liu, Gao-Qiang Cai, Guo-Qing Liao. Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective studyWorld Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01840-9
2
K. M. Ingley, M. Zatzman, A. M. Fontebasso, W. Lo, V. Subasri, A. Goldenberg, Y. Li, S. Davidson, N. Kanwar, L. Waldman, L. Brunga, Y. Babichev, E. G. Demicco, A. Gupta, M. Szybowska, S. Thipphavong, D. Malkin, A. Villani, A. Shlien, R. A. Gladdy, R. H. Kim. Genomic and clinical characterization of a familial GIST kindred intolerant to imatinibnpj Genomic Medicine 2024; 9(1) doi: 10.1038/s41525-024-00405-z
3
Newton A.C.S. Wong, Christel Garcia-Petit, Adam Dangoor, Nicola Andrew. A literature review and database of how the primary KIT/PDGFRA variant of a gastrointestinal stromal tumour predicts for sensitivity to imatinibCancer Genetics 2022; : 46 doi: 10.1016/j.cancergen.2022.09.002
4
Mara Fornasarig, Daniela Gasparotto, Luisa Foltran, Michele Campigotto, Sara Lombardi, Elisa Del Savio, Angela Buonadonna, Fabio Puglisi, Sandro Sulfaro, Vincenzo Canzonieri, Renato Cannizzaro, Roberta Maestro. A Novel Kindred with Familial Gastrointestinal Stromal Tumors Caused by a Rare KIT Germline Mutation (N655K): Clinico-Pathological Presentation and TKI SensitivityJournal of Personalized Medicine 2020; 10(4): 234 doi: 10.3390/jpm10040234